Product Information
LITHIUM CARBONATE 150 MG CAP is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.0873 per EA under NDC 31722054401. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
150 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722054401
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LITHIUM CARBONATEApproval Type
Generic (ANDA)
FDA Application
ANDA090702On Market Since
12/15/2009
Pharmacological Classes
Price Statistics
The NADAC for LITHIUM CARBONATE 150 MG CAP has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 32.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0873 per EA |
|---|---|
| All-time high | $0.1032 (Jan 10, 2024) |
| All-time low | $0.0499 (Nov 18, 2015) |
| 52-week high | $0.0896 |
| 52-week low | $0.0847 |
| Median price | $0.0783 |
| Average price | $0.0768 |
| Largest weekly change | +27.7% (Dec 23, 2015) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the lithium carbonate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of LITHIUM CARBONATE 150 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for LITHIUM CARBONATE 150 MG CAP, manufactured by Camber Pharmaceuticals Inc., is $0.0873 per EA (NDC 31722054401), effective Jun 24, 2026.
How has the price of LITHIUM CARBONATE 150 MG CAP changed over time?
Over the history we have for it, the NADAC for LITHIUM CARBONATE 150 MG CAP has risen 32.6%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LITHIUM CARBONATE 150 MG CAP?
Since Nov 28, 2013, the NADAC for LITHIUM CARBONATE 150 MG CAP has ranged from a low of $0.0499 (Nov 18, 2015) to a high of $0.1032 (Jan 10, 2024), with a median of $0.0783 per EA.
Are there cheaper alternatives to LITHIUM CARBONATE 150 MG CAP?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of LITHIUM CARBONATE 150 MG CAP, so no direct lower-cost alternative is listed.
Who manufactures LITHIUM CARBONATE 150 MG CAP?
LITHIUM CARBONATE 150 MG CAP (NDC 31722054401) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification